ChemoCentryx (CCXI) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to ChemoCentryx (CCXI) Tops Q4 EPS by 2c

ChemoCentryx Reports Fourth Quarter 2015 Financial Results and Provides Corporate Update

March 14, 2016 4:06 PM EDT

-- Successful Phase II CLEAR Clinical Trial Demonstrated Rapid Onset of Benefit While Eliminating Need for Chronic High-Dose Steroids in ANCA-Associated Vasculitis (AAV) With Complement Inhibitor CCX168 --

-- Enrollment Now Complete in AAV Phase II CLASSIC Trial of CCX168; Top Line Data Expected mid-2016 --

-- Pancreatic Cancer Clinical Trial of CCX872 Completes Enrollment Ahead of Schedule; Initial Response Rate Data Expected in the First Half of 2016 and Initial Progression Free Survival Results Expected in the Second Half of 2016 --

-- Conference Call Today at 5:00... More